scholarly journals CHALLENGES OF CREATING A CLIENT-ORIENTED STRATEGY IN AN ONLINE PHARMACEUTICAL ORGANIZATION

Author(s):  
S.Y Kondratov ◽  
◽  
M.I Kimadze ◽  
2021 ◽  
Vol 104 (3) ◽  
pp. 460-465

Background: The prevalence of spasticity in multiple sclerosis (MS) patients is nearly 90%. Most patients do not respond to current anti-spastic medications. Objective: To evaluate the efficacy and safety of Government Pharmaceutical Organization cannabis extract (GPOCE) in the treatment of spasticity in MS patients in Thailand. Materials and Methods: This prospective pilot study in patients diagnosed with MS whose spasticity was not relieved under current spasticity treatments, was performed between November 2019 and June 2020. The GPOCE formulation of THC:CBD 1:1 was administered to all patients. The treatment outcomes were determined at 12 weeks and compared with their baseline. Results: Seven patients participated in the present study. Among these, two patients withdrew after receiving only a small dose of GPOCE. Finally, five patients were included in the final analysis. The primary outcome was a reduction in the Modified Ashworth Score (MAS), which decreased among participants from a baseline of 15 (IQR 12 to 19) to 6 (IQR 1 to 12) (p=0.043). The key secondary outcome was a clinically relevant response (CRR), which was defined as a reduction of the spasticity Numeric Rating Scale (NRS) of more than thirty percent compared to baseline. Four patients (80%) achieved CRR. Moreover, the overall spasticity NRS decreased from a median of 6 (IQR5 to 7) to 2 (IQR2 to 3). A reduction of other NRS parameters, including fatigue, pain, tremor, sleep, spasm, anxiety, and depression, was also observed after treatment. Moreover, GPOCE was generally well tolerated. Conclusion: GPOCE is useful in treating spasticity in patients with MS. The safety profile is acceptable under the supervision of a health care provider. Keywords: Multiple sclerosis (MS), Cannabis extract, Spasticity


Author(s):  
Paul Drake

This entry concerns a live application in which the principles of communities of practice have been used to supplement the delivery of a critical business process. The company concerned is a multinational pharmaceutical organization with annual sales in the order of £20bn and a workforce of 100,000 employees worldwide. One of the more critical IT services provided is that which defends the organisation’s computer systems against attack by malicious software (commonly called computer viruses). This service draws significant direct and indirect resources to provide an acceptable level of defence for the organization. The service manages the provision of this defence from the gathering of intelligence concerning latest threats through deployment of protective measures to reporting of metrics showing service performance and adequacy of defences.


2016 ◽  
Vol 136 (10) ◽  
pp. 1415-1425 ◽  
Author(s):  
Tomohisa Yasuhara ◽  
Hiroki Kondo ◽  
Misa Nagata ◽  
Kana Iwata ◽  
Taro Kushihata ◽  
...  

2011 ◽  
Vol 39 (5) ◽  
pp. 581-604 ◽  
Author(s):  
Abhradip Banerjee ◽  
Arnab Das ◽  
Gopalkrishna Chakrabarti

Abstract The present article aims at providing some detailed insights into the cultural and ethical dimensions of pharmaceutical sales and marketing practices in India. The first author had six months of experience in the field of pharmaceutical marketing. This experience has been used as a means to understand the complementary elements of the subject concerned like business-network, strategies, roles and relations of various stakeholders, nature of exchange as well as intentions around transactions and practices from an insider’s perspective. By a continuous interpretation of multiple layers of consciousness implicit within the first author’s experience and with systematic recreation of his reactions, this article shows how Indian drug representatives are trained, what they do on a daily basis and also about their socialization process within corporate culture which has long eluded the anthropological studies of pharmaceuticals. Thus, it provides an ethnographic perspective or representation of how the networks, relations and ideologies are structured and organized, and in general, how things work in the Indian pharmaceutical industry.


2021 ◽  
Vol 5 (1) ◽  
pp. 001-009
Author(s):  
Esraa Mahadi Ali Mohamed ◽  
Khalid Sayid Abdelgadir Habbani ◽  
Mohamed Awad Mousnad

Background: Drugs are one of the most crucial pillars in the provision of healthcare services and achieving Universal Health Coverage (UHC). Life-Saving Drugs (LSDs) are the drugs that save someone’s life, require immediate administration in most of the cases, as they sustain life, and prevent complications. They are top priority healthcare needs, which required to be available and aff ordable at all time in adequate quantities and low cost for the whole population and thus achieving equity. Since pharmaceutical sector in Sudan is highly fragmented, this study is conducted to determine the degree of stakeholders’ knowledge about the defi nition of LSD, whether there is a policy governing them, if they have a standard list and their availability status in Sudan. Methods: G rounded theory qualitative (exploratory) study design. The theory is grounded from the actual data after being collected and analysed. Results: Only essential medicines is the well-known term for the stakeholders -mainly at the governance level- with its policy and list. The other LSDs terminologies were found to be ambiguous, with no policies or standard lists. The status of the availability of the diff erent LSDs terminologies (as it perceived by each stakeholder) was found to be poor and there is a signifi cant shortage mainly due to the economic issues. Conclusions: Unifi cation of pharmaceutical organization in Sudan is a must and a priority issue due to its ultimate importance in the provision of healthcare services. Consensus and participation of all the relevant stakeholders in designing policies is an important input for a well-designed health system governance. Further researches in diff erent areas must be conducted, and awareness of policymakers and service providers must be raised.


Author(s):  
Berezhnaya E.S.

Gathering information is a key component of market research marketing. The search and analysis of marketing information is carried out through four auxiliary systems, namely, an internal reporting system, a system for collecting external current marketing information, a system of marketing research and analysis of marketing information. Based on the information received, marketing research of the drug market is carried out and the needs of the population for pharmaceutical products are studied. Among the many areas of marketing research on the activities of pharmacies, the study of the range of sold medical and pharmaceutical goods in order to determine ways to optimize it is of paramount importance. A prerequisite for marketing research is the study of drugs as a product, its main pharmacotherapeutic properties, indications for use, release forms and other merchandising characteristics. It is important to analyze the assessments of consumer properties and indicators of use for each name of medicinal products in the assortment of a pharmaceutical organization. This article provides approaches to the definition of the assortment policy of the enterprise, gives the classification of the assortment of the enterprise «Pharmacy of low prices». The groups of drugs are identified depending on their effect on the pharmacy income. Based on consumer preferences, the main positions of the assortment of pharmacies, which are needed by consumers of the city of Penza and the Penza region, have been determined. Along with determining the optimal assortment of the pharmacy and the number of drugs for each pharmaceutical group on sale, it is important to determine the optimal ratio of drugs for each pharmaceutical group. An algorithm for the formation of a new assortment of the Low-Price Pharmacy enterprise has been developed. Recommendations for improving the assortment policy of the «Low Price Pharmacy» enterprise are offered. The features of pharmaceutical marketing of the market of non-prescription and prescription drugs have been studied. Optimization of the product policy of pharmacy organizations, taking into account the distribution of drugs by pharmaceutical trade groups, will ensure the survival of small-scale retailers in a competitive environment.


2016 ◽  
Vol 5 (6) ◽  
pp. 74-78
Author(s):  
Папанова ◽  
S. Papanova ◽  
Ледовской ◽  
E. Ledovskoy

In this article the main approaches to optimization of activity of the pharmaceutical organizations in the context of a psychological reflection of an image of a drugstore in corporate culture of the pharmaceutical organization are considered. The existing contradiction in consciousness of consumers in the field of perception of pharmaceutical goods and services, is also shown concerning visitors of drugstores to workers of the first table: to pharmacists and druggists. It is essentially important to heads of the pharmaceutical organizations to find the optimal solution for emotional support of personnel. Such unique phenomenon of modern management as corporate culture can play a key role in this situation. Thanks to an involvement of employees at the enterprise the strong command spirit, the atmosphere of mutual assistance and mutual understanding will be able to be created that will promote in turn resistance to stress of workers, to emergence of enthusiasm and internal motivation of members of collective constantly to self-improve in the sphere of the professional activity. Ability of the management of the pharmaceutical organization to build the system of management based on corporate culture with use of the principles of an involvement can guarantee prosperity of business in the long term.


2015 ◽  
Vol 3 (5(12)) ◽  
pp. 60
Author(s):  
N. M. Sergeeva ◽  
E. V. Reprintseva

Sign in / Sign up

Export Citation Format

Share Document